Skip to main content
Fig. 6 | BMC Ophthalmology

Fig. 6

From: Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism

Fig. 6

ARHGAP9 is associated with the sensitivities of parental Y79 cells to carboplatin and etoposide. a Knockdown of ARHGAP9 in parental Y79 cells with siRNA detected by real time QRT-PCR. b Cellular sensitivities of parental Y79 cells to etoposide and carboplatin after downregulation of ARHGAP9 by CCK-8 assays. Data are expressed as mean ± SEM. c Relative expression levels of ARHGAP9 in parental Y79 and Y79/EDR cells after treated with carboplatin and etoposide. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us